GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Equity-to-Asset

The Searle Co (KAR:SEARL) Equity-to-Asset : 0.51 (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is The Searle Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. The Searle Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₨32,569 Mil. The Searle Co's Total Assets for the quarter that ended in Dec. 2024 was ₨63,304 Mil. Therefore, The Searle Co's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.51.

The historical rank and industry rank for The Searle Co's Equity-to-Asset or its related term are showing as below:

KAR:SEARL' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.36   Med: 0.55   Max: 0.69
Current: 0.51

During the past 13 years, the highest Equity to Asset Ratio of The Searle Co was 0.69. The lowest was 0.36. And the median was 0.55.

KAR:SEARL's Equity-to-Asset is ranked worse than
61.68% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs KAR:SEARL: 0.51

The Searle Co Equity-to-Asset Historical Data

The historical data trend for The Searle Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Searle Co Equity-to-Asset Chart

The Searle Co Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.52 0.51 0.48 0.51

The Searle Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.50 0.51 0.52 0.51

Competitive Comparison of The Searle Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, The Searle Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Searle Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Searle Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where The Searle Co's Equity-to-Asset falls into.


;
;

The Searle Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

The Searle Co's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=32531.223/63560.769
=0.51

The Searle Co's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=32569.08/63304.274
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Searle Co  (KAR:SEARL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


The Searle Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of The Searle Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


The Searle Co Business Description

Traded in Other Exchanges
N/A
Address
Tipu Sultan Road, Plot No. 1, One IBL Centre, 2nd Floor, Block 7 and 8, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.

The Searle Co Headlines

No Headlines